9 January 2018

Pim Assendelft, theme Healthcare Improvement Science, discusses the role of the physician in prevention in a recent issue of the Netherlands Journal of Medicine (‘NTVG’).


Pim Assendelft

The role of prevention in medical care has recently been described and discussed in various strategy reports by Dutch medical professional organisations. However, there are still doubts concerning the effectiveness and feasibility of practicing preventive medicine. Both inconclusive evidence on its effectiveness, including on long-term outcomes of preventive medicine interventions, and studies showing positive results have been published. In general, more intensive approaches towards lifestyle change are more effective. Regarding disease-related prevention intervention, various authors stress that this is undoubtedly a task reserved for physicians. Their degree of responsibility and input is less clear when it comes to indicated and selective prevention. Nonetheless, for these latter types of prevention there seems to be a role reserved for the physician, given the increase in lifestyle-related chronic diseases and the prevalence of social class related health inequity. Here, the author argues that physicians are ideally positioned as advisor and motivator, especially towards more vulnerable patients. Preventive aftercare can then be organised in partnership with other providers. To take an active role in prevention still needs 'guts', and physicians are challenged to take a position in this.

read article

Related news items


First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more

Stofwisselkracht grant for Daan Panneman and Richard Rodenburg

16 January 2020

Daan Panneman & Richard Rodenburg have been awarded a Stofwisselkracht grant for their proposal “CRISPR/Cas9 knock-in complementation in fibroblasts of mitochondrial disease patients”. Together with Omar Tutakhel & Jan Smeitink they will investigate the possibility of using CRISPR/Cas9 knock-in.

read more

The PRIDE Study Evaluation of online methods of data collection

16 January 2020

In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.

read more

Laparoscopy reduces the number of adhesions but it is still too high

14 January 2020

Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.

read more

Radboud Talks 2020 scientific pitch competition

14 January 2020

The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.

read more

Review Sanne Frambach accepted by Pharmacological Reviews

13 January 2020

In this review entitled 'Brothers in arms: ABCA1 and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment', RIMLS researcher Sanne Frambach, describe the possibilities for stimulating cellular efflux.

read more